Literature DB >> 25786274

Etymologia: Bonferroni correction.

.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 25786274      PMCID: PMC4313667          DOI: 10.3201/eid2102.et2102

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


× No keyword cloud information.

Bonferroni [bonʹfər-ōʺni] Correction

Named after Italian mathematician Carlo Emilio Bonferroni (1892–1960) but first attributed to Olive Jean Dunn, the Bonferroni correction compensates for multiple comparisons by dividing the significance level by the number of comparisons. The significance level is the probability that a given test will incorrectly find a difference in the sample that is not present in the population (false positive). A significance level of 0.05 is a commonly accepted significance level. If a study tested 5 comparisons, there would be up to a 25% likelihood (0.05 + 0.05 + 0.05 + 0.05 + 0.05) that any one of them would show a significant difference by chance. The Bonferroni correction adjusts for this by dividing the significance level by the number of tests. In this case, the significance level for a given comparison would be 0.01, for an overall risk no larger than 0.05 of falsely detecting a difference. This technique has been criticized as too conservative, particularly when a large number of tests are used, and it may increase the risk for a false negative. Other tests, such as the Tukey-Kramer and Scheffe method, may reduce this risk.
  3 in total

Review 1.  What's wrong with Bonferroni adjustments.

Authors:  T V Perneger
Journal:  BMJ       Date:  1998-04-18

2.  Multiple hypothesis testing and Bonferroni's correction.

Authors:  Philip Sedgwick
Journal:  BMJ       Date:  2014-10-20

3.  Multiple significance tests: the Bonferroni method.

Authors:  J M Bland; D G Altman
Journal:  BMJ       Date:  1995-01-21
  3 in total
  8 in total

1.  Specific Changes in Arabidopsis thaliana Rosette Lipids during Freezing Can Be Associated with Freezing Tolerance.

Authors:  Hieu Sy Vu; Sunitha Shiva; Thilani Samarakoon; Maoyin Li; Sujon Sarowar; Mary R Roth; Pamela Tamura; Samuel Honey; Kaleb Lowe; Hollie Porras; Neema Prakash; Charles A Roach; Morgan Stuke; Xuemin Wang; Jyoti Shah; Gary Gadbury; Haiyan Wang; Ruth Welti
Journal:  Metabolites       Date:  2022-04-23

2.  Public Views on Models for Accessing Genomic and Health Data for Research: Mixed Methods Study.

Authors:  Kerina H Jones; Helen Daniels; Emma Squires; David V Ford
Journal:  J Med Internet Res       Date:  2019-08-21       Impact factor: 5.428

3.  A network pharmacology approach to reveal the protective mechanism of Salvia miltiorrhiza-Dalbergia odorifera coupled-herbs on coronary heart disease.

Authors:  Fei Li; Jialin Duan; Meina Zhao; Shaojie Huang; Fei Mu; Jing Su; Kedi Liu; Yang Pan; Xinming Lu; Jing Li; Peifeng Wei; Miaomiao Xi; Aidong Wen
Journal:  Sci Rep       Date:  2019-12-18       Impact factor: 4.379

4.  Rural-urban differences in health outcomes, healthcare use, and expenditures among older adults under universal health insurance in China.

Authors:  Meiling Ying; Sijiu Wang; Chen Bai; Yue Li
Journal:  PLoS One       Date:  2020-10-12       Impact factor: 3.240

5.  Associative Overdominance and Negative Epistasis Shape Genome-Wide Ancestry Landscape in Supplemented Fish Populations.

Authors:  Maeva Leitwein; Hugo Cayuela; Louis Bernatchez
Journal:  Genes (Basel)       Date:  2021-04-03       Impact factor: 4.096

6.  A plasma metabolite score of three eicosanoids predicts incident type 2 diabetes: a prospective study in three independent cohorts.

Authors:  Karolina Tuomisto; Joonatan Palmu; Tao Long; Jeramie D Watrous; Kysha Mercader; Kim A Lagerborg; Allen Andres; Marko Salmi; Sirpa Jalkanen; Ramachandran S Vasan; Michael Inouye; Aki S Havulinna; Jaakko Tuomilehto; Pekka Jousilahti; Teemu J Niiranen; Susan Cheng; Mohit Jain; Veikko Salomaa
Journal:  BMJ Open Diabetes Res Care       Date:  2022-03

7.  HLA-DQA1 & DQB1 variants associated with hepatitis B virus-related chronic hepatitis, cirrhosis & hepatocellular carcinoma.

Authors:  Vijay Kumar Karra; Soumya Jyoti Chowdhury; Rajesh Ruttala; Phani Kumar Gumma; Sunil Kumar Polipalli; Anita Chakravarti; Premashis Kar
Journal:  Indian J Med Res       Date:  2018-06       Impact factor: 2.375

8.  Single cell sequencing analysis identifies genetics-modulated ORMDL3+ cholangiocytes having higher metabolic effects on primary biliary cholangitis.

Authors:  Bingyu Xiang; Chunyu Deng; Fei Qiu; Jingjing Li; Shanshan Li; Huifang Zhang; Xiuli Lin; Yukuan Huang; Yijun Zhou; Jianzhong Su; Mingqin Lu; Yunlong Ma
Journal:  J Nanobiotechnology       Date:  2021-12-06       Impact factor: 10.435

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.